Dynamic range of hepatitis C virus RNA quantification with the cobas ampliprep-cobas amplicor HCV monitor v2.0 assay

Journal of Clinical Microbiology

Volumn 43, Issue 4, 2005, Pages 1669-1673

  Gourlain, Karine ^a   Soulier, Alexandre ^a   Pellegrin, Bertrand ^a   Bouvier Alias, Magali ^a   Hézode, Christophe ^a,b   Darthuy, Françoise ^a   Rémiré, Jocelyne ^a   Pawlotsky, Jean Michel ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ARTICLE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DILUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MONITOR; MULTICENTER STUDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE;

ANTIVIRAL AGENTS; AUTOMATION; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC; RIBAVIRIN; RNA, VIRAL; VIRAL LOAD;

EID: 16844365875     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.4.1669-1673.2005     Document Type: Article

References (10)

1. Consensus panel. 2002. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 36:S3-S20.
2. Enomoto, M., S. Nishiguchi, S. Shiomi, M. Tanaka, K. Fukuda, T. Ueda, A. Tamori, D. Habu, T. Takeda, Y. Yano, and S. Otani. 2001. Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus. J. Gastroenterol. Hepatol. 16:904-909.
3. Lee, S. C., A. Antony, N. Lee, J. Leibow, J. Q. Yang, S. Soviero, K. Gutekunst, and M. Rosenstraus. 2000. Improved version 2.0 qualitative and quantitative Amplicor reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J. Clin. Microbiol. 38:4171-4179.
4. Martell, M., J. Gomez, J. I. Esteban, S. Sauleda, J. Quer, B. Cabot, R. Esteban, and J. Guardia. 1999. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 37:327-332.
5. Neumann, A. U., E. Hagai, S. W. Schalm, M. von Wagner, G. Germanidis, Y. Lurie, G. Missale, M. Martell, J. M. Vrolijk, C. Hezode, G. Norkrans, F. Negro, A. Soulier, E. Verheij-Hart, G. Colucci, C. Ferrari, S. Zeuzem, and J. M. Pawlotsky. 2003. Early viral kinetics prediction of sustained virological response after 1 or 4 weeks of peginterferon alfa-2a and ribavirin therapy (DITTO project). Hepatology 38:248A.
6. Pawlotsky, J. M. 2002. Molecular diagnosis of viral hepatitis. Gastroenterology 122:1554-1568.
7. Pawlotsky, J. M. 2002. Use and interpretation of virological tests for hepatitis C. Hepatology 36:S65-S73.
8. Pawlotsky, J. M., C. Hezode, B. Pellegrin, A. Soulier, M. von Wagner, J. T. Brouwer, G. Missale, G. Germanidis, Y. Lurie, F. Negro, J. I. Esteban, K. Hellstrand, C. Ferrari, S. Zeuzem, S. W. Schalm, and A. U. Neumann. 2002. Early HCV genotype 4 replication kinetics during treatment with peginterferon alfa-2a (Pegasys)-ribavirin combination. A comparison with HCV genotypes 1 and 3 kinetics. Hepatology 36:291A.
9. Pawlotsky, J. M., and J. G. McHutchison. 2004. Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Hepatology 39:554-567.
10. Takeuchi, T., A. Katsume, T. Tanaka, A. Abe, K. Inoue, K. Tsukiyama-Kohara, R. Kawaguchi, S. Tanaka, and M. Kohara. 1999. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 116:636-642.